Am I high, or is psychedelic use no longer a relatively small, counterculture phenomenon?
According to Quartz, psychedelic drugs are entering a second golden age in the U.S. and Europe, after a decades-long dark age that followed the collapse of government-backed—and sometimes scientifically dubious—research on LSD and psilocybin (the active compound in magic mushrooms) in the hippie heydays of the 1960s.
While they remain legally classified as Schedule 1 narcotics, psychedelics—particularly when consumed in regular, sub-hallucinogenic “microdoses” rather than in a single mind-blowing “trip”—are producing promising results in medical labs at prestigious universities.
If the sheer volume of press is any measure, interest in microdosing is surging, and getting a leg up in one’s career seems to be a major motivator, reports Forbes. And the tech world, eternally obsessed with efficiency, has become a breeding ground for “biohacking” one’s body—including compressing an hours-long trip into a ten-minute break.
DMT, often nicknamed “the spirit molecule,” is commonly accepted as the world’s most potent and exploratory psychedelic. According to Vice, this chemical compound found in ayahuasca—a plant blend drunk ceremonially by South American tribes for centuries—can now be found in a vape cartridge for a quick rush of trancendental bliss, instead of a full mind-shaking, perception-shifting breakthrough.
Innovative delivery methods, combined with DMT’s short duration of action, and a spike in popularity could lead to a revolutionary new line of psychiatric medicines—including a simple patch you wear on your skin.